European Infection Control Market

The infection control market is projected to reach USD 20.58 billion by 2030 from USD 14.99 billion in 2025, at a CAGR of 6.6% during the forecast period.

The market for infection control is growing due to several factors, including the increasing prevalence of healthcare-associated infections (HAIs), the rising number of surgeries, advancements in reprocessing technology, the growing focus on sterilization and disinfection in the food industry, improvements in sterilization equipment technology, and the increasing trend of outsourcing of services. However, concerns about the safety of reprocessed instruments, consequences associated with chemical disinfectants, and high costs associated with endoscopy reprocessing are expected to restrain market growth to a certain extent.

The European Infection Control Market is competitive, featuring companies like STERIS plc. (US), Getinge AB (Sweden), Ecolab, Inc. (US), Solventum Corporation (US), Advanced Sterilization Products (US), Kimberly-Clark Corporation (US), B. Braun Group (Germany), Olympus Corporation (Japan), Paul Hartmann AG (Germany), Reckitt Benckiser (UK), Cardinal Health (US), Miele Group (Germany), MMM Group (Germany), MATACHANA GROUP (Spain), Medline Industries, LP (US), Contec, Inc. (US), De Lama S.p.A. (Italy), Systec GmbH & Co. KG (Germany), Pal International (UK), Melag Medizintechnik GmbH & Co. KG (Germany), MEDALKAN (Greece), C.R.M. S.R.L. Medical Equipment (Italy), Dr. Schumacher GmbH (Germany), ACTO GmbH (Germany), and Ultrawave (UK). These market players have implemented several strategies, including product launches, acquisitions, agreements, collaborations, and expansions, to enhance their positions in the market.

To know about the assumptions considered for the study download the pdf brochure

STERIS continues strengthening its position as a powerhouse in the infection control market through strategic acquisitions and expanded service capabilities. In August 2023, the company finalized a USD 540 million acquisition of surgical instrumentation and sterilization container assets from Becton, Dickinson and Company, including recognized brands such as V. Mueller, Snowden-Pencer, and Genesis, which added approximately USD 170 million in annual revenue and broadened STERIS’s healthcare segment offerings in sterile processing and surgical tools.

Reckitt Benckiser is a key leader in the European Infection Control space, accounting for the second-largest share of the market. Reckitt Benckiser has sharpened its strategic focus on infection control across Europe by doubling its core Power Brands Dettol and Lysol while streamlining its broader brand portfolio to concentrate on high-growth, high-margin categories. Notably, in November 2022, Reckitt launched a co-branded professional hygiene product range in partnership with Essity, integrating Dettol and Sagrotan into Essity’s Tork distribution network across the UK, Germany, Ireland, and Austria. This initiative was designed specifically for institutional settings such as healthcare facilities and represented Reckitt’s deliberate expansion into professional-use infection control solutions.

Paul Hartmann AG has reinforced its leadership in European infection prevention by expanding its Mission: Infection Prevention initiative launched in 2020 in collaboration with clinical partners and the WHO’s Patient Safety Day, focusing on common HAIs and offering consultancy, digital hygiene monitoring, and tailored disinfection plans through its BODE Science Center.

Market Ranking

The European infection control market is primarily led by STERIS, Reckitt Benckiser, and Paul Hartmann AG, each distinguished by its leadership in sterilization, hygiene, and barrier solutions. These companies command the largest share of the European infection control market due to their comprehensive portfolios, ongoing innovation, robust global footprint, and strategic expansion efforts. STERIS plc (US/Ireland) asserts its market-leading position in Europe through a comprehensive infection control portfolio that spans sterilization systems (EtO, e-beam, gamma), washer-disinfectors, surgical instrument care, and contract sterilization services.

Reckitt Benckiser (UK) commands a leading share in the surface disinfectant market in Europe through its trusted antiseptic brands—Dettol, Lysol, and Sagrotan. With substantial brand equity and deep institutional penetration, Reckitt leverages strategic partnerships, including its collaboration with Essity/Tork in 2022 and its distribution alliance with Diversey, to cement its reach into healthcare, facility management, and food-service channels.

Paul Hartmann AG (Germany) plays an instrumental role in European infection prevention through its integral Infection Management division, which comprises barrier solutions, glove and apparel offerings, and its flagship disinfectant brand, Sterillium. With strategic initiatives like its Mission: Infection Prevention program and expansion of Sterillium manufacturing capacity in Hamburg (2022), Hartmann has strengthened production and availability across Europe.

Related Reports:

European Infection Control Market by Product (Sterilization Equipment (Hydrogen Peroxide, Ethylene) Indicators), Service (ETO, Gamma), Disinfectants (Wipes, Sprays), Gown, Drapes, Endoscope Reprocessing, End User (Hospitals, Pharma) - Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com